Report: New HIV Diagnoses in District Drop 46 Percent Between 2007 and 2011

In 2011, 15,056 District residents, or 2.4 percent of the entire population, were living with HIV or AIDS and 718 new cases of HIV were reported, an improvement in a city that has historically been ranked as having the highest prevalence of the disease in the nation, according to an annual report released by the mayor’s office today.

Some highlights from the 2012 District of Columbia HIV/AIDS, Hepatitis, STD and TB Epidemiology Annual Report:

  • The reported found the number of newly diagnosed HIV decreased from 1,333 new cases in 2007 to 718 in 2011, a decline of 46 percent.
  • The leading cause of HIV transmission was sexual contact between heterosexual and same-sex partners.
  • There was an 80 percent decrease in the number of HIV cases caused by injected drugs with needles, from 149 cases in 2007 (before the District’s needle-exchange program began) to 30 in 2011.

Perry Stein
Washington City Paper
Read More

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search